Please login to the form below

Not currently logged in
Email:
Password:

Otezla

This page shows the latest Otezla news and features for those working in and with pharma, biotech and healthcare.

Amgen raises forecasts after closing $13.4bn Otezla deal

Amgen raises forecasts after closing $13.4bn Otezla deal

Amgen lost no time completing its acquisition of psoriasis blockbuster Otezla in the wake of the Bristol-Myers Squibb/Celgene merger, and promptly raised its 2019 sales forecasts. ... Amgen says it expects “at least low double-digit percentage Otezla

Latest news

More from news
Approximately 10 fully matching, plus 25 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Infographic: RA Perceptions

    The greatest levels of familiarity and interest were reported for novel small molecules such as Celgene’s Otezla (apremilast) and Pfizer’s Xeljanz (tofacitinib), which both offer a new oral alternative ... Of the physicians who were familiar with

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics